Giorgio Bogani
University of Insubria
CancerInternal medicineObstetricsSurgeryOncologyRetrospective cohort studySentinel nodeStage (cooking)Prospective cohort studyChemotherapyEndometrial cancerCervical cancerHysterectomyLaparoscopyOvarian cancerLymphadenectomyRadical HysterectomyGynecologyGeneral surgeryMedicine
262Publications
28H-index
3,218Citations
Publications 257
Newest
#1Violante Di Donato (Sapienza University of Rome)H-Index: 21
#2Giuseppe Caruso (Sapienza University of Rome)H-Index: 17
Last. Gianluca Terrin (Sapienza University of Rome)H-Index: 30
view all 13 authors...
Source
Background null To evaluate the performance of a decision support system (DSS) based on radiomics and machine learning in predicting the risk of malignancy of ovarian masses (OMs) from transvaginal ultrasonography (TUS) and serum CA-125. null Methods null A total of 274 consecutive patients who underwent TUS (by different examiners and with different ultrasound machines) and surgery, with suspicious OMs and known CA-125 serum level were used to train and test a DSS. The DSS was used to predict t...
Source
#1Khaled Ghoniem (Mayo Clinic)H-Index: 1
#2Alyssa Larish (Mayo Clinic)H-Index: 3
Last. Francesco RaspagliesiH-Index: 57
view all 37 authors...
Abstract null null Objective null To assess oncologic outcomes in endometrial cancer patients with low-volume metastasis (LVM) in the sentinel lymph nodes (SLNs). null null null Methods null Patients with endometrial cancer and SLN-LVM (≤2 mm) from December 3, 2009, to December 31, 2018, were retrospectively identified from 22 centers worldwide. Patients with International Federation of Gynecology and Obstetrics (FIGO) stage IV, adnexal involvement, or unknown adjuvant therapy (ATx) were exclude...
Source
#1Jvan Casarin (University of Insubria)H-Index: 20
#2Antonella Cromi (University of Insubria)H-Index: 54
Last. Fabio Ghezzi (University of Insubria)H-Index: 73
view all 6 authors...
OBJECTIVE To estimate rate of perioperative complications and to define risk factors of 30-day major (Clavien-Dindo ≥ 2) postoperative complications of total laparoscopic hysterectomy (TLH) for benign disease. STUDY DESIGN An uncontrolled single-center single-arm retrospective study. Data of consecutive patients who have undergone TLH for pathologically confirmed benign disease between January 2000 and December 2019 have been analyzed. Perioperative surgical outcomes, occurrence of postoperative...
Source
Source
#1Giorgia Mangili (UniSR: Vita-Salute San Raffaele University)H-Index: 18
#2Giorgio GiordaH-Index: 20
Last. Alice Bergamini (UniSR: Vita-Salute San Raffaele University)H-Index: 14
view all 19 authors...
Objective The aim of this study was to analyze the oncological outcome of stage I malignant ovarian germ cell tumors patients included in the MITO-9 study to identify those who might be recommended routine surveillance alone after complete surgical staging. Methods MITO-9 was a prospective observational study analyzing data collected between January 2013 and December 2019. Three groups were identified: group A included 13 patients stage IA dysgerminoma and IAG1 immature teratoma; group B include...
Source
#1Giorgio BoganiH-Index: 28
#2Giuseppe SarpietroH-Index: 9
Last. Francesco RaspagliesiH-Index: 57
view all 11 authors...
Abstract The Enhanced Recovery After Surgery (ERAS) is a pathway designed to achieve early recovery for patients undergoing major surgery. The ERAS pathway included three important components preoperative, intraoperative, postoperative program. Pre-habilitation and re-habilitation are of paramount importance to improve patients’ care. The ERAS is based on evidence-based medicine. Accumulating evidence highlighted that adopting ERAS resulted in lower complication rate, and shorter length of hospi...
2 CitationsSource
Objective To explore the clinical and biological prognostic factors for advanced ovarian cancer patients receiving first-line treatment with carboplatin, paclitaxel, and bevacizumab. Methods A multicenter, phase IV, single arm trial was performed. Patients with advanced (FIGO (International Federation of Gynecology and Obstetrics) stage IIIB-IV) or recurrent, previously untreated, ovarian cancer received carboplatin (AUC (area under the curve) 5), paclitaxel (175 mg/m2) plus bevacizumab (15 mg/k...
Source
#1G Bogani (Yahoo!)H-Index: 1
#2Isabelle Ray-Coquard (UCBL: Claude Bernard University Lyon 1)H-Index: 77
Last. Bradley J. Monk (UA: University of Arizona)H-Index: 51
view all 32 authors...
Serous endometrial cancer represents a relative rare entity accounting for about 10% of all diagnosed endometrial cancer, but it is responsible for 40% of endometrial cancer-related deaths. Patients with serous endometrial cancer are often diagnosed at earlier disease stage, but remain at higher risk of recurrence and poorer prognosis when compared stage-for-stage with endometrioid subtype endometrial cancer. Serous endometrial cancers are characterized by marked nuclear atypia and abnormal p53 ...
Source
#1Violante Di DonatoH-Index: 21
#2Giuseppe CarusoH-Index: 17
Last. Giorgio BoganiH-Index: 28
view all 11 authors...
Objective: The aim of this meta-analysis was to discuss evidence supporting the efficacy of adjuvant human papillomavirus (HPV) vaccination in reducing the risk of recurrent cervical intraepithelial neoplasia (CIN) 2 or greater after surgical treatment. Methods: A systematic literature search was performed for studies reporting the impact of HPV vaccination on reducing the risk of recurrence of CIN 2+ after surgical excision. Results were reported as mean differences or pooled odds ratios (OR) w...
Source